📰 Codexis Inc News
Page 2 - Codexis Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Codexis Inc. Real-time updates on events, politics, business and more.
April 2, 2024
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has earned an average rating of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price target among […]
March 31, 2024
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has received an average rating of “Moderate Buy” from the six analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target price among […]
March 24, 2024
Takeda Pharmaceutical (NYSE:TAK – Get Free Report) and Nurix Therapeutics (NASDAQ:NRIX – Get Free Report) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Volatility and Risk Takeda Pharmaceutical has a beta […]
February 29, 2024
Codexis, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.16.
February 28, 2024
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Codexis Inc. (CDXS) on Wednesday reported a loss of $7.2 million in its fourth quarter.
February 28, 2024
28.02.2024 - Anticipate 2024 Product Revenue Growth of at Least 10% vs. 2023 Excluding Enzyme Sales Related to PAXLOVID Recently Announced Debt Financing Reinforces Strong Financial Position with Projected Runway Through Expected Positive Cash-flow Around End ...
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE:HLX) fell sharply during Tuesday’s session following weak earnings. Helix Energy posted...
February 20, 2024
Board expertise encompasses oligonucleotide research, development, manufacturing and commercialization to support development of ECO Synthesis™...
February 20, 2024
REDWOOD CITY, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the appointment of Masad Damha, PhD, and Jim Lalonde, PhD,